Alkermes Granted Orphan Drug Designations for Alixorexton in US, Europe
Key takeaways: The US FDA granted orphan drug designation to alixorexton for the treatment of idiopathic hypersomnia, while…
#Europe #EU #EuropeanCommission #Alkermes #IdiopathicHypersomnia #Narcolepsy #OrphanDrug #OX2R
https://www.europesays.com/europe/71303/